IN2014DN02984A - - Google Patents

Info

Publication number
IN2014DN02984A
IN2014DN02984A IN2984DEN2014A IN2014DN02984A IN 2014DN02984 A IN2014DN02984 A IN 2014DN02984A IN 2984DEN2014 A IN2984DEN2014 A IN 2984DEN2014A IN 2014DN02984 A IN2014DN02984 A IN 2014DN02984A
Authority
IN
India
Prior art keywords
salt
pain
hyperphagia
azetidin
eases
Prior art date
Application number
Other languages
English (en)
Inventor
Derek A Beauchamp
Kenneth M Wells
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IN2014DN02984A publication Critical patent/IN2014DN02984A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN2984DEN2014 2011-09-30 2012-09-27 IN2014DN02984A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161541281P 2011-09-30 2011-09-30
PCT/US2012/057461 WO2013049287A1 (en) 2011-09-30 2012-09-27 Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin- 1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders

Publications (1)

Publication Number Publication Date
IN2014DN02984A true IN2014DN02984A (de) 2015-05-15

Family

ID=47046853

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2984DEN2014 IN2014DN02984A (de) 2011-09-30 2012-09-27

Country Status (11)

Country Link
US (1) US8835417B2 (de)
EP (1) EP2760861A1 (de)
JP (1) JP2014528427A (de)
KR (1) KR20140072897A (de)
CN (1) CN104271573A (de)
AR (1) AR088198A1 (de)
CA (1) CA2849779A1 (de)
IN (1) IN2014DN02984A (de)
MX (1) MX342140B (de)
TW (1) TW201329073A (de)
WO (1) WO2013049287A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
US4337341A (en) * 1976-11-02 1982-06-29 Eli Lilly And Company 4a-Aryl-octahydro-1H-2-pyrindines
US8106208B2 (en) * 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
FR2915198B1 (fr) * 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
CA2759614C (en) * 2009-04-22 2017-09-19 Janssen Pharmaceutica Nv Azetidinyl diamides as monoacylglycerol lipase inhibitors

Also Published As

Publication number Publication date
WO2013049287A1 (en) 2013-04-04
US8835417B2 (en) 2014-09-16
US20130085279A1 (en) 2013-04-04
TW201329073A (zh) 2013-07-16
MX2014003898A (es) 2014-12-05
KR20140072897A (ko) 2014-06-13
MX342140B (es) 2016-09-14
CA2849779A1 (en) 2013-04-04
CN104271573A (zh) 2015-01-07
AR088198A1 (es) 2014-05-14
EP2760861A1 (de) 2014-08-06
JP2014528427A (ja) 2014-10-27

Similar Documents

Publication Publication Date Title
MX2011008276A (es) Inhibidores de quinasa jun n-terminal.
MX2012007273A (es) Pteridinonas como inhibidores de la quinasa tipo polo.
NZ705135A (en) Heteroaryl compounds and methods of use thereof
EA201001126A1 (ru) Пирролопиримидины и пирролопиридины
TN2011000282A1 (en) Alkaloid aminoester derivatives and medicinal composition thereof
MX2009009590A (es) Aminopirimidinas utiles como inhibidores de proteinas cinasas.
AU2012258977A8 (en) Inhibitors of LRRK2 kinase activity
GB0906579D0 (en) Pharmaceuticals, compositions and methods of making and using the same
IN2012DN02968A (de)
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
HK1136827A1 (en) Spirocyclic cyclohexane derivatives
MY156332A (en) Quinuclidine carbonate derivatives and medicinal composition thereof
HK1136828A1 (en) Spirocyclic cyclohexane derivatives
WO2012096929A3 (en) Heteroaryl compounds and methods of use thereof
PH12015500860A1 (en) 2-phenyl -5- heterocyclyl -tetrahydro-2h- pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
IN2014MN02380A (de)
IN2012DN03182A (de)
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
MX350862B (es) Acidos de piperidinil naftilacetico.
MX2010009756A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos.
TN2012000191A1 (en) Quinuclidine compounds as alpha-7nicotinic acetylcholine receptor ligands
IN2013DN02555A (de)
MX2011011618A (es) Agentes terapeuticos 713.
DE602007004327D1 (de) Einen azepin-kern enthaltende antagonisten des histaminrezeptors
IN2014DN02984A (de)